Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Ajanta Pharma Ltd (AJPH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,372.00 +138.90    +6.22%
03/05 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE031B01049 
S/N:  AJANTPHARM
  • Volume: 73,366
  • Bid/Ask: 2,377.00 / 2,377.00
  • Day's Range: 2,360.00 - 2,531.95
Ajanta Pharma Ltd 2,372.00 +138.90 +6.22%

NS:AJPH Financials

 
A brief overview of the NS:AJPH financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Ajanta Pharma Ltd over time.

Ajanta Pharma Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 10,540.8 million compared to INR 8,818.4 million a year ago. Revenue was INR 10,895.8 million compared to INR 9,186.7 million a year ago. Net income was INR 2,027.2 million compared to INR 1,222.5 million a year ago. Basic earnings per share from continuing operations was INR 16.1 compared to INR 9.54 a year ago. Diluted earnings per share from continuing operations was INR 16.09 compared to INR 9.54 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

AJPH Income Statement

Gross margin TTM 75.16%
Operating margin TTM 26.11%
Net Profit margin TTM 19.01%
Return on Investment TTM 23.92%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 10895.8 11051.5 10284.4 10210.4
Gross Profit 8252 8109.8 7723.2 7691.4
Operating Income 2795.7 2873.9 2569.5 2481.3
Net Income 2027.2 2100.3 1953 2081.2

AJPH Balance Sheet

Quick Ratio MRQ 1.91
Current Ratio MRQ 3.05
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.99%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 46383.9 44332.3
Total Liabilities 10710.3 9513.6
Total Equity 35673.6 34818.7 34818.7 33879.9

AJPH Cash Flow Statement

Cash Flow/Share TTM 62.35
Revenue/Share TTM 340.97
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AJPH Comments

Write your thoughts about Ajanta Pharma Ltd-BO
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Surat Aulakh
Surat Aulakh May 16, 2020 2:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If you can keep this for 3 years stock will hit 30000 price that 2000% of CMP ..but for midium period target is 7500-8000
Surat Aulakh
Surat Aulakh May 16, 2020 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target is 2000%
Surat Aulakh
Surat Aulakh May 16, 2020 2:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So keep buying it keep buying it at any cost
Surat Aulakh
Surat Aulakh May 16, 2020 2:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is the time to buy it as it will not give you any chance after that
Surat Aulakh
Surat Aulakh May 16, 2020 2:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Strongly buy for the target of 7500 in the month of december 2020
Surat Aulakh
Surat Aulakh May 16, 2020 2:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy it
Abbas Midda
Abbas Midda Mar 08, 2019 4:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1805.tarja
jitendra gupta
jitendra gupta Feb 08, 2019 4:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
only creat short position
Prateek Dhuper
Prateek Dhuper Mar 26, 2018 11:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong buy @ current levels for 1462
Jivitesh Dhanuka
Jivitesh Dhanuka Nov 02, 2017 6:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong buy at 1252, tgt 1320,sl 1240.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email